RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..5 of 5 - per page
Order by
An OTC benign mucosal protective throat spray; capable of relieving chronic sore throat, cough, hoarseness, and post-nasal drip; the symptoms of acid reflux in addition to environmental and other throat conditions.
Powder spray providing a benign mucosal barrier over the entire throat, combating the reflux related symptoms of stomach acid and enzymes in the throat, utilizing a purified, organic, safe and effective natural compound. More
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Tackling challenges of poor solubility
Enhancing the dissolution performance of small and large molecules in a range of dosage forms More
Stabilisation and rapid reconstitution of biopharmaceuticals
Improving the reconstitution and increasing the stability of biomolecules using supercritical fluid (SCF) processing More
Displaying 1..5 of 5 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Esophagitis - Pipeline Review, Q4 2010
Nov 2010 - 50 pages - $500
Esophagitis - Pipeline Review, Q2 2011
May 2011 - 45 pages - $500
Eosinophilic Esophagitis Global Clinical Trials Review, Q1, 2011
Mar 2011 - 40 pages - $1,000
Esophagitis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 46 pages - $1,000
Gastrointestinal Drug Discoveries
Jan 2008 - 148 pages - $1,740
Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2011
Sep 2011 - 97 pages - $500
Hokkaido Gastrointestinal Cancer Study Group – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 30 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 41 pages - $500
Spanish Cooperative Group for Gastrointestinal Tumour Therapy – Developmental Therapeutics Review – Q1 2011
Mar 2011 - 41 pages - $500
Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG) – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 40 pages - $500
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us